Voloridge Investment Management, LLC Cel Sci Corp Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $144,681 - $279,829	-56,078 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.93 - $7.7 $891,155 - $1.75 Million	-226,757 Reduced 80.17%	56,078 $220,000
Q4 2021 Feb 14, 2022	SELL	$7.1 - $12.82 $1.88 Million - $3.39 Million	-264,271 Reduced 48.3%	282,835 $2.01 Million
Q3 2021 Nov 15, 2021	BUY	$7.64 - $12.49 $3.07 Million - $5.02 Million	402,270 Added 277.74%	547,106 $6.01 Million
Q2 2021 Aug 16, 2021	BUY	$8.68 - $27.49 $1.26 Million - $3.98 Million	144,836 New	144,836 $1.26 Million

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $30.4M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.